Skip to main content
Premium Trial:

Request an Annual Quote

National Institute on Drug Abuse Awards Gene Logic $6 Million Contract For Preclinical Studies of Medications to Treat Drug Addiction

NEW YORK, Oct. 8 (GenomeWeb News) - Gene Logic announced today that it will receive up to $6 million over the next four years from the National Institute on Drug Abuse to provide preclinical safety and pharmacology studies focused on developing safe and effective medications for the treatment of drug addiction.

 

Under terms of the agreement, Gene Logic will perform studies and services requested by NIDA. The studies will focus on developing safety data for selected compounds that have already been demonstrated to be efficacious in animal models.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.